Volume : 10, Issue : 05, May – 2023
Title:
24.FORMULATION AND EVALUATION OF MICROSPONGES LOADED TOPICAL GEL FOR TREATMENT OF ACNE VULGARIS
Authors :
Diksha D. Ghorpade* and Dr. S. C. Atram
Abstract :
Abstract:
The purpose of present study aims to design novel drug delivery system containing adapalene microsponges and to prepare microsponge gel. Adapalene is an anti-acne drug used in the treatment of acne infection having a poor aqueous solubility, side effects and adverse reactions. The microsponge delivery system is unique technology for controlled / sustained release of active agents. The microsponges were prepared by quasi-emulsion solvent diffusion method by using polymer Eudragit S-100 and Eudragit RS -100. All the formulated microsponges were subjected for various evaluation parameters such as production yield, encapsulation efficiency, particle size analysis and in vitro drug release study. The optimized microsponge formulation F4 and F8 were further formulated as gel formulation for topical delivery. Prepared gel was evaluated for physical parameters like pH, spreadability, viscosity, drug content and in vitro diffusion study and compared with the other formulation. The Differential scanning calorimetry (DSC), XRD, Zeta potential and Particle size of drug and excipient confirm compatibility.
Results revealed that quasi-emulsion solvent diffusion method is a suitable technique for the preparation of microsponges as most of the formulations were discrete and spherical in shape with a good production yield of 51.88 % to 89.41% and the highest drug release for MGF4 and MGF8 formulation was found to be 87.77 % and 83.24 % respectively for the 8 h. The drug release of microsponges gel is 91.31% .The drug release data of optimized batch MGI (F4) were fitted into different kinetic models and showed that the drug release from gel formulation follows zero order release. As compared to conventional formulation, the prepared microsponge gel are expected to remain on the skin for a longer time, gradually releasing their contents over the time. Hence, adapalene microsponges and microsponge gel prepared in this study are promising as being more useful than conventional formulation therapy.
Keywords: Adapalene, Microsponge, Anti acne drug, Microsponge gel, Topical delivery
Cite This Article:
Please cite this article in press Diksha D. Ghorpade et al, Formulation And Evaluation Of Microsponges Loaded Topical Gel For Treatment Of Acne Vulgaris., Indo Am. J. P. Sci, 2023; 10 (05).
Number of Downloads : 10
References:
1. Kaundal A, Bhatia R, Sharma A, Sukrial P. A review on microsponge’s drug delivery system. IN J Advs. Pharm 2014; 4:177-81.
2. Yeti RM, Atta DA, Elmazar MM, El-Nabarawi MA, Teaima MH. Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness. Drug Design, Development and Therapy. 2022 Jan 1:3847-64.
3. Waugh J, Noble S, Scott LJ. Adapalene. Drugs. 2004; 64(13):1465–1478
4. Irby CE, Yangtze BA, Feldman SR. A review of adapalene in the treatment of acne vulgaris. J Doles Health. 2008; 43(5):421–424.
5. Chatter a, Nattouf A. Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner. Scientific Reports. 2022 Jul 6; 12(1):11414.
6. Shalita, A. et al. Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: A multicenter, double-blind, randomized, parallel-group study. J. Drugs Dermatol. 4, 153–158 (2005).
7. Stein Gold LF, Alexis AF, Harper JC, Tan JKL. Advances in Acne and Rosacea Therapy. Semin Cutan Med Surg. 2018 Jun; 37(3S):S63-S66.
8. Tan J, Bissonnette R, Gratton D, Kerrouche N, Canosa JM. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study. Eur J Dermatol. 2018 Aug 01; 28(4):502-508.
9. Bagatin E, Gonçalves HS, Sato M, Almeida LMC, Miot HA. Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging. Eur J Dermatol. 2018 Jun 01; 28(3):343-350.
10. Rusu A, Tanase C, Pascu GA, Todoran N. Recent Advances Regarding the Therapeutic Potential of Adapalene. Pharmaceuticals (Basel). 2020 Aug 28; 13(9)5.
11. Patel N, Padia N, Vadgama N, Raval M, Sheth N. Formulation and evaluation of microsponge gel for topical delivery of fluconazole for fungal therapy. Journal of Pharmaceutical Investigation. 2016 Jun; 46:221-38.
12. Riyaz Ali M Osmani, Aloorkar NH, Ingale DJ, Kulkarni PK, Umme Hani, Bhosale RR, et al. Microsponge based novel drug delivery system for augmented arthritis therapy. Saudi Pharm J 2015; 23:562-72.
13. P Yadav, S Nanda. Development and evaluation of some microsponge loaded medicated topical formulations of acyclovir. Int J Pharm Sky Res 2014; 5:1395-410.
14. Yadav V, Jadhav P, Dombe S, Bodhe A, Salunkhe P. Formulation and evaluation of microsponge gel for topical delivery of antifungal drug. International Journal of Applied Pharmaceutics. 2017 Jul 13:30- 8 of 43 V 99.
15. . Hussain H, Dhyani A, Juyal D, Bahuguna A. Formulation and evaluation of gel-loaded microsponges of diclofenac sodium for topical delivery. The Pharma Innovation. 2014 Dec 1; 3(10, Part B):58. 101.
16. Katkade M, Kalkotwar R, Jain N, Patti P, Gadakh R, Naikwade J. Ethyl cellulose based microsponge delivery system for antifungal vaginal gels of ticonazole. J Drug Delivery Ther 2013; 3:14-20.